Skip to main content

The Microcirculation in Cardiac Hypertrophy

  • Conference paper
Idiopathic Dilated Cardiomyopathy
  • 94 Accesses

Abstract

Left ventricular hypertrophy has long been associated with increased risk of fatal and nonfatal cardiovascular events. In the Framingham experience, individuals with EKG evidence of left ventricular hypertrophy had an approximately five fold increased risk of death, new onset of angina pectoris, or nonfatal myocardial infarction [23]. Recent studies have shown that over one-third of hypertensive patients have measurable increases in left ventricular mass, even if the EKG is normal [13, 15]: these patients also represent a high-risk group for cardiovascular events [11, 26]. Several observations in humans with left ventricular hypertrophy, whether primary (e.g., hypertrophic cardiomyopathy) or secondary (e.g., hypertension, aortic stenosis) suggest that myocardial ischemia may mediate many of these events, such as complaints of anginalike chest pain, often with abnormal noninvasive testing similar to that seen in patients with coronary artery disease [9, 19, 28, 53]. Because epicardial coronary arteries commonly appear normal during angiography, consideration has been made that the coronary microcirculation may be abnormal in structure or function in patients with left ventricular hypertrophy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bonow RO, Rosing DR, Bacharach SL, Green MV, Kent KM, Lipson LC, Maron BJ, Leon MB, Epstein SE (1981) Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 64:787–796

    Article  PubMed  CAS  Google Scholar 

  2. Bostrom SL, Fryklund J (1979) Protein synthesis and composition of cardiac and vascular tissue in spontaneously hypertensive rats and the effects of beta-adrenergic antagonist treatment. Clin Sci 57:39–41

    Google Scholar 

  3. Brilla CG, Janicki JS, Weber KT (1991) Diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 69:107–115

    PubMed  CAS  Google Scholar 

  4. Brush JE, Cannon RO, Schenke WH, Bonow RO, Leon MB, Maron BJ, Epstein SE (1988) Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 319:1302–1307

    Article  PubMed  Google Scholar 

  5. Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, Parodi O, Salvadori PA, Nista N, Papi L, L’Abbate A (1991) Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardio- myopathy: a study with nitrogen-12 ammonia and positron emission tomography. J Am Coll Cardiol 17:879–886

    Article  PubMed  CAS  Google Scholar 

  6. Cannon RO, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, Epstein SE (1985) Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 71:234–243

    Article  PubMed  Google Scholar 

  7. Cannon RO, Schenke WH, Maron BJ, Tracy CM, Leon MB, Brush JE, Rosing DR, Epstein SE (1987) Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive cardio- myopathy. J Am Coll Cardiol 10:53–62

    Article  PubMed  Google Scholar 

  8. Cannon RO, McIntosh CL, Schenke WH, Maron BJ, Bonow RO, Epstein SE (1989) Effects of surgical reduction of left ventricular outflow obstruction on hemodynamic, coronary flow and myocardial metabolism in hypertrophic cardiomyopathy. Circulation 79:766–775

    Article  PubMed  Google Scholar 

  9. Cannon RO, Dilsizian V, O’Gara PT, Udelson JE, Schenke WH, Quyyumi A, Fananapazir L, Bonow RO (1991) Myocardial metabolic, hemodynamic and electrocardiographic sig- nificance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Cir- culation 83:1660–1667

    Google Scholar 

  10. Cannon RO, Dilsizian V, O’Gara PT, Udelson JE, Tucker E, Panza JA, Fananapazir L, McIntosh CL, Wallace RB, Bonow RO (1992) Impact of operative relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathy. Circulation 85 (in press)

    Google Scholar 

  11. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH (1986) Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 105:173–178

    PubMed  CAS  Google Scholar 

  12. Cutilletta AF, Dowell RT, Rudnik M, Ardila RA, Zak R (1975) Regression of myocardial hypertrophy. I. Experimental model, changes in heart weight, nucleic acids and collagen. J Mol Cell Cardiol 7:767–781

    Article  CAS  Google Scholar 

  13. Devereux RB, Savage DD, Sachs I, Laragh JH (1983) Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. Am J Cardiol 51:171–176

    Article  PubMed  CAS  Google Scholar 

  14. Eberli FR, Ritter M, Schwitter M, Bortone A, Schneider J, Hess OM, Krayenbuehl HP (1991) Coronary reserve in patients with arotic valve disease before and after successful aortic valve replacement. Eur Heart J 12:127–138

    PubMed  CAS  Google Scholar 

  15. Hammond IW, Devereux RB, Aldeman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JH (1986) The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 7:639–650

    Article  PubMed  CAS  Google Scholar 

  16. Harrison DG, Florentine MS, Brooks LA, Cooper SM, Marcus ML (1988) The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation 77:1108–1115

    Article  PubMed  CAS  Google Scholar 

  17. Henquell L, Odoroff CC, Honig CR (1977) Intercapillary distance and capillary reserve in hypertrophied rat hearts beating in situ. Circ Res 41:400–408

    PubMed  CAS  Google Scholar 

  18. Holtz J, Restorff WV, Bard P, Bassenge E (1977) Transmural distribution of myocardial blood flow of coronary reserve in canine left ventricular hypertrophy. Basic Res Cardiol 72:286–292

    Article  PubMed  CAS  Google Scholar 

  19. Houghton JL, Frank MJ, Carr AA, Von Dohlen TW, Prisant LM (1990) Relations among impaired coronary flow reserve, left ventricular hypertrophy, and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 15:43–51

    Article  PubMed  CAS  Google Scholar 

  20. Isoyama S, Ito N, Kuroha M, Takishima T (1989) Complete reversibility of physiological coronary vascular abnormalities in hypertrophied hearts produced by pressure overload in the rat. J Clin Invest 84:288–294

    Article  PubMed  CAS  Google Scholar 

  21. Isoyama S, Sato F, Takishima T (1991) Effect of age on coronary circulation after imposition of pressure-overload in rats. Hypertension 17:369–377

    PubMed  CAS  Google Scholar 

  22. Ito N, Isoyama S, Kuroha M, Takishima T (1990) Duration of pressure overload alters regression of coronary circulation abnormalities. Am J Phsiol 258:H1753-H1760

    CAS  Google Scholar 

  23. Kannel WB, Gordon T, Offutt D (1969) Left ventricular hypertrophy by electro- cardiogram: prevalence, incidence, and mortality in the Framingham Study. Ann Intern Med 71:89–105

    PubMed  CAS  Google Scholar 

  24. Klepzig M, Eisenlohr H, Steindl J, Schmiebusch H, Strauer BE (1987) Media hypertrophy in hypertensive coronary resistance vessels. J Cardiovasc Pharmacol10 [Suppl 6]:S97-S102

    PubMed  Google Scholar 

  25. Koyanagi S, Eastham CL, Harrison DG, Marcus ML (1982) Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res 50:55–62

    PubMed  CAS  Google Scholar 

  26. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561–1566

    Article  PubMed  CAS  Google Scholar 

  27. Lundin SA, Hallback-Nordlander M (1984) Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats. J Hypertension 2:11–18

    Article  CAS  Google Scholar 

  28. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL (1982) Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med 307:1362–1366

    Article  PubMed  CAS  Google Scholar 

  29. Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8:545–557

    Article  PubMed  CAS  Google Scholar 

  30. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy. Interrelation of clinical manifestations, pathophysiology and therapy. N Engl J Med 316:780–789

    Article  PubMed  CAS  Google Scholar 

  31. Motz W, Strauer BE (1989) Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 13:43–50

    PubMed  CAS  Google Scholar 

  32. Mueller TM, Marcus ML, Kerber RE, Young JA, Barnes RW, Abboud FM (1978) Effect of renal hypertension and left ventricular hypertrophy on the coronary circulation in dogs. Circ Res 42:543–549

    PubMed  CAS  Google Scholar 

  33. O’Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL, Larson SM, Epstein SE (1987) Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy; assessment with thallium-201 computed tomography. Circulation 76: 1214–1223

    Article  PubMed  Google Scholar 

  34. O’Keefe DD, Hoffman JE, Chietlin M, O’Neill JO, Allard JR, Shapkin E (1978) Coronary blood flow in experimental canine left ventricular hypertrophy. Circ Res 43:43–51

    PubMed  Google Scholar 

  35. Opherk D, Mall G, Zebe H, Schwarz F, Weihe E, Manthey J, Kubier W (1984) Reduction of coronary reserve: a mechanism for angina pectoris and normal coronary arteries. Cir- culation 69:1–7

    CAS  Google Scholar 

  36. Polese A, De Cesare N, Montorsi P, Fabbiocchi F, Guazzi M, Loaldi A, Guazzi MD (1991) Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation 83:845–853

    PubMed  CAS  Google Scholar 

  37. Rakusan K (1971) Quantitative morphology of capillaries of the heart. Number of capillaries in animal and human hearts under normal and pathological conditions. Methods Achiev Exp Pathol 5:272–286

    PubMed  CAS  Google Scholar 

  38. Rembert JC, Kleinman LH, Fedor JM, Wechsler AS, Greenfield JC (1978) Myocardial blood flow distribution in concentric left ventricular hypertrophy. J Clin Invest 62:379–386

    Article  PubMed  CAS  Google Scholar 

  39. Sano T, Tarazi RC (1987) Differential structural responses of small resistance vessels to antihypertensive therapy. Circulation 75:618–626

    Article  PubMed  CAS  Google Scholar 

  40. Sato F, Isoyama S, Takishima T (1990) Normalization of impaired coronary circulation in hypertrophied rat hearts. Hypertension 16:26–34

    PubMed  CAS  Google Scholar 

  41. Schwartzkopff B, Vogt M, Knauer S, Motz W, Strauer BE (1991) Medial hypertrophy of intramural coronary arteries in patients with reduced coronary reserve in hypertensive heart disease. Circulation 84:II-479 (abstr)

    Google Scholar 

  42. Sen S, Tarazi RC, Bumpus FM (1981) Reversal of cardiac hypertrophy in renal hyper- tensive rats: medical versus surgical therapy. Am J Physiol 240:H408-H412

    PubMed  CAS  Google Scholar 

  43. Strauer BE (1979) Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 44:999–1002

    Article  PubMed  CAS  Google Scholar 

  44. Strauer BE (1979) Myocardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy, and coronary reserve. Am J Cardiol 44:730–740

    Article  PubMed  CAS  Google Scholar 

  45. Tanaka M, Fujiwara H, Onodera T, Wu D-J, Matsuda M, Hamashima Y, Kawai C (1987) Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 6:1130–1139

    Article  Google Scholar 

  46. Tomanek RJ, Searls JC, Lachenbruch PA (1982) Quantitative changes in the capillary bed during developing, peak, and stabilized cardiac hypertrophy in the spontaneously hypertensive rat. Circ Res 51:295–304

    PubMed  CAS  Google Scholar 

  47. Tomanek RJ, Aydelotte MR, Butters CA (1990) Late-onset renal hypertension in old rats alters myocardial microvessels. Am J Physiol 259:H1681-H1687

    PubMed  CAS  Google Scholar 

  48. Treasure CB, Lein JL, Vita JA, Selwyn AP, Alexander RW, Ganz P (1991) Left ventricular hypertrophy secondary to hypertension is associated with impaired endothelium-mediated relaxation in the coronary microvessels. J Am Coll Cardiol 17:237A (abstr)

    Article  Google Scholar 

  49. Udelson JE, Bonow RO, O’Gara PT, Maron BJ, Van Lingen A, Bacharach SL, Epstein SE (1989) Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 79:1052–1060

    Article  PubMed  CAS  Google Scholar 

  50. Vogt M, Motz W, Schwartzkopff B, Strauer BE (1990) Coronary microangiopathy and cardiac hypertrophy. Eur Heart J 11 [Suppl B]:133–138

    PubMed  Google Scholar 

  51. Vogt M, Motz W, Politz B, Scheler S, Strauer BE (1991) Improvement of coronary reserve by chronic treatment with ACE-inhibitors. Circulation 84:II-136 (abstr)

    Google Scholar 

  52. Warshaw DM, Root DT, Halpern W (1980) Effects of antihypertensive drug therapy on the morphology and mechanics of resistance arteries from spontaneously hypertensive rats. Blood Vessels 17:257–270

    PubMed  CAS  Google Scholar 

  53. Wasserman AD, Katz RJ, Varghese PJ, Leiboff RH, Bren GG, Schlesselman S, Varma VM, Reba RC, Ross AM (1984) Exercise radionuclide ventriculographic responses in hypertensive patients with chest pain. N Engl J Med 311:1276–1280

    Article  PubMed  CAS  Google Scholar 

  54. Wearn JT (1928) The extent of the capillary bed of the heart. J Exp Med 47:273–292

    Article  PubMed  CAS  Google Scholar 

  55. Yamori Y, Mori C, Nishio T, Ooshima A, Horie R, Ohtaka M, Soeda T, Saito M, Abe K, Nara Y, Nakao Y, Kihara M (1979) Cardiac hypertrophy in early hypertension. Am J Cardiol 44:964–969

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Cannon, R.O. (1993). The Microcirculation in Cardiac Hypertrophy. In: Figulla, HR., Kandolf, R., McManus, B. (eds) Idiopathic Dilated Cardiomyopathy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77891-9_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77891-9_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77893-3

  • Online ISBN: 978-3-642-77891-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics